Peptide Bioconjugates: an Emerging Strategy in the Pharmacotherapy of Dermatological Diseases (2015-2025). A Review
Year: 2026
Type: article
Abstract: Peptide-based bioconjugates are emerging as a highly versatile and powerful class of therapeutics in modern dermatology, offering precise molecular targeting combined with the flexibility of advanced chemical design. These systems demonstrate broad applicability — from antimicrobial and anti-inflammatory interventions to photodynamic and antineoplastic therapies — while addressing key limitations of conventional treatments through controlled delivery, sustained release, and enhanced cellular selectivity. Ongoing advancements in peptide engineering, linker chemistry, and conjugation strategies will be critical for successful clinical translation. The systematic review examines the most recent advances in peptide-based therapeutics across major dermatological conditions, highlighting translational progress achieved between 2015 and 2025.
Institutions: University of Opole, Medical University of Lublin
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: diamond
Funder: Uniwersytet Medyczny w Lublinie
Award: G8421355087
OpenAlex ID: W7225379624
